CRDO Down 20.3% in a Month: Is the Weakness an Opportunity?

Credo Technology shares fell 20.3% over the past month despite fiscal Q1 2027 revenue rising 114.7% year over year to $479 million and non-GAAP operating margin reaching 48.2%. Management expects fiscal 2027 revenue growth above 85%, supported by AEC demand and more than $600 million of projected optical revenue, but the stock trades at 11.1x forward sales versus 5.0x for its sub-industry. Concentration remains a key risk, with the two largest customers accounting for 61% of quarterly revenue, alongside rising R&D costs and fluid tariff assumptions.

Analysis

CRDO is transitioning from a single-product AI cluster-connectivity supplier toward a broader optical stack, but that transition temporarily raises the bar: investors must underwrite simultaneous ramps in AEC, DSP, and silicon photonics rather than extrapolate a mature cable cycle. The key second-order issue is that higher optical content can expand TAM but may dilute the exceptional margin profile if initial yields, packaging costs, or customer qualification cycles resemble other optical-component ramps. MRVL is the more diversified incumbent beneficiary if hyperscalers broaden vendor qualification; ALAB remains the cleaner adjacent read-through on AI fabric complexity without CRDO's cable-to-optics execution risk.

The near-term risk is not an AI-capex collapse but deployment timing. With a small customer set driving most demand, one customer moving a cluster build by a quarter could create a sharp revenue-guide reset and multiple compression disproportionate to the underlying demand change. At a premium revenue multiple, even sustained growth is insufficient if sequential growth decelerates before the newer products contribute materially; watch next-quarter implied sequential revenue, gross margin, and the optical-revenue trajectory rather than headline year-over-year growth.

Contrarian view: the selloff may be underpricing the strategic value of qualified 1.6T connectivity suppliers, where qualification friction can make revenues stickier than the market assumes. But that is a fiscal-2028 thesis, while the next 1-3 months remain dominated by proof that new optical products are shipping at attractive margins. The appropriate expression is selective, not an outright chase: CRDO needs evidence that diversification is reducing—not merely adding to—customer and product-cycle risk.

Key Decisions for Investors

• Maintain CRDO as a watch-to-buy rather than add immediately; initiate only after the next earnings release confirms sequential growth above management's implied run-rate and no gross-margin degradation from the optical ramp. Target a 6-12 month position sized below typical AI-infrastructure holdings; exit on a revenue-guide cut or evidence that either of the two largest customers defers deployments.
• Use a 3-6 month pair trade: long MRVL / short CRDO in equal dollar amounts for investors seeking AI-connectivity exposure with lower single-customer risk. The thesis wins if optical qualification or customer timing shifts demand toward diversified suppliers; close if CRDO demonstrates sustained optical revenue conversion with stable operating margins.
• For upside participation, prefer CRDO call spreads dated beyond the next two earnings reports rather than outright shares, only if implied volatility permits a defined-risk structure. The catalyst is credible 1.6T product revenue and raised fiscal-2028 optical expectations; the risk is a 20%+ gap lower on a single hyperscaler schedule change.
• Track ALAB earnings and hyperscaler capex commentary as a sector-demand cross-check. Strength in ALAB's fabric/connectivity demand alongside weak CRDO results would point to company-specific execution or share loss, supporting the MRVL/CRDO relative-value trade rather than a broad reduction in AI-networking exposure.